← Open Payments lookup

RACHEL POVILUS: Open Payments

NPI 1750980298 · LONGMONT, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,650 in 107 payments from 19 companies in 2025. Trend: 2023 $3,055 · 2024 $4,542 · 2025 $2,650

Food & beverage: $2,650
CompanyPaymentsAmount
ABBVIE INC.25$430
Gilead Sciences, Inc.13$269
Madrigal Pharmaceuticals7$243
Takeda Pharmaceuticals U.S.A., Inc.7$191
PFIZER INC.5$176
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$171
Aimmune Therapeutics, Inc.8$153
Mirum Pharmaceuticals, Inc.1$145
GENZYME CORPORATION5$138
Amgen Inc.1$132

Products named: REZDIFFRA, DUPIXENT, XIFAXAN, ENTYVIO, ZENPEP, Livmarli, VELSIPITY, UPLIZNA.

Industry payments across CO — which companies pay providers there.